Research and Markets: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/ct8qx9/acute_lymphocytic) has announced the addition of the "Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Mentioned

Partial list of the 80 companies featured in this report:

  1. 4SC AG
  2. Bexion Pharmaceuticals
  3. Calithera Biosciences
  4. Daiichi Sankyo Company
  5. Epirus Biopharmaceuticals
  6. Fate Therapeutics
  7. Gamida Cell
  8. Hangzhou Minsheng Pharmaceutical
  9. iDD biotech
  10. Jasco Pharmaceuticals
  11. KaloBios Pharmaceuticals
  12. medac
  13. Novartis
  14. Onconova Therapeutics
  15. Pfenex
  16. Quimatryx
  17. Sanofi
  18. Theravectys
  19. Verastem
  20. Xenetic Biosciences

For more information, including full list of companies mentioned, please visit http://www.researchandmarkets.com/research/ct8qx9/acute_lymphocytic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology